The Longevity Data Company

Longevity Medicine · Clinical Data Registry · MSO Platform

The infrastructure
layer for longevity
medicine.

We own physician-led longevity clinics and partner with medical associations to build the data registry that longevity medicine has never had — and the clinical intelligence layer that activates it.

For Physicians Investor Overview

6K+

Patient-Years at Clinic A

300K+

Patient-years at scale (50+ clinics)

Unified longevity registries today

The Problem

Longevity medicine is generating extraordinary data.
Almost none of it is being captured.

Every longevity clinic runs its own isolated experiment. Protocols evolve through individual physician intuition — not cross-clinic evidence. In every other field of medicine, multi-site data has been the unlock. Longevity medicine has no equivalent. Yet.

The MSO Model

We acquire cash-pay longevity clinics and absorb non-clinical functions — so physicians focus entirely on patients. Unified HR, finance, and operational infrastructure across owned clinics.

The Data Registry

Owned clinics and network partners contribute to a proprietary longitudinal health registry — de-identified, multi-site, outcomes-linked. The kind of data asset that doesn't exist in longevity medicine today. The registry is not a warehouse. It is the foundation for clinical intelligence — designed to power protocol optimization and real-world evidence at scale.

The Compounding Asset

Owned clinics anchor data quality. Partnerships with medical associations scale the network. Each path reinforces the other — the data asset compounds faster than the clinic count. And as the registry deepens, so does the intelligence it generates. Data compounds. Protocols improve. The moat widens.

Physician Governance

This is not a PE rollup. Physicians retain clinical autonomy. INEXION takes the administrative burden. Mission-aligned structure — built to last beyond any single exit.

For Clinic Physicians

We take the burden.
You focus on patients.

INEXION is not a private equity rollup. We acquire growth-minded longevity practices and absorb everything that isn't clinical — so your practice can scale without sacrificing the mission.

Biomarker Testing

Vitals & Monitoring

Hormone Optimization

Multi-Modal Protocols

Longevity Outcomes

Operational Relief

INEXION absorbs HR, payroll, IT, compliance, and finance. Your administrative burden disappears at close. Physicians stay in clinical mode — always.

Revenue Upside

Unified marketing engine, patient acquisition support, and a subscription model that generates recurring, predictable revenue. Biologics revenue sharing across the portfolio.

Clinical Autonomy

You retain full clinical authority. INEXION governs operations — not medicine. Physician-led governance is a structural commitment, not a talking point.

Data & Research Access

Join a multi-clinic longevity data platform. Your patient outcomes contribute to a shared registry — publishable, outcomes-linked, and built to advance the field.

We're looking for growth-minded physicians running practices that are 80%+ dedicated to longevity medicine.

Start the Conversation

The Registry Thesis

One clinic at a time.
One patient-year at a time.

Patient-years are the unit of measurement that matters. Each INEXION clinic acquired adds longitudinal depth to the registry — and external clinics can participate too, contributing de-identified data in exchange for access to the platform. This open-participation model is a data growth accelerator: the registry compounds faster than any single acquisition strategy could. At scale the data platform becomes the primary asset — not the clinic count. As the registry grows, so does the intelligence it generates — turning longitudinal outcomes into continuously improving longevity protocols.

6K+

Patient-Years · Clinic A

Seed stage. First acquisition establishes the registry baseline and operational proof of concept. External clinic participation opens immediately.

40K+

Patient-Years · Series A Trigger

3–5 clinic portfolio. Registry activation. Cross-site outcomes analysis becomes possible for the first time.

300K+

Patient-Years · Scale · 50+ Clinics

50+ clinics — INEXION-owned and external participants. Registry becomes publishable, licensable, and the foundation for clinical research partnerships.

Investor Overview

The compounding opportunity
in longevity's data gap.

Longevity medicine is a massive, fragmented market with no unified infrastructure. INEXION is building the layer that doesn't exist — an MSO platform with a data registry that appreciates with every acquisition.

Market Opportunity

The global longevity market is large, fast-growing, and structurally fragmented. Thousands of independent cash-pay clinics operate without shared infrastructure, unified brand, or any mechanism to aggregate outcomes data. The $128B TAM spans longevity and regenerative care broadly; INEXION's immediate SAM is the $27B independent cash-pay clinic market — ~5,000 practices with no platform consolidating them at scale.

$128B+

TAM — U.S. longevity & regenerative care

$27B+

SAM — Independent cash-pay clinic market

~5,000

Independent clinics in the US

Capital Strategy

We are raising a seed round from family offices and super angels — investors who understand the healthcare services space and share the long-term vision. No VC pressure. No premature exit horizon. We are designed to compound.

Family Offices Super Angels Minimal Dilution Seed Stage $500M–$1B Valuation Target

Data Asset Moat

Every INEXION clinic acquired adds patient-years to the registry. External clinics can participate directly — contributing de-identified data in exchange for platform access. This open-participation model is a data growth accelerator: the registry compounds faster than any acquisition strategy alone could achieve. The data asset becomes publishable, licensable, and the foundation for clinical research partnerships. This is the Flatiron Health model applied to longevity medicine — built from the start to be activated by clinical AI, not just stored.

Seed · Clinic A (INEXION)

6K+ patients

Series A · 3–5 INEXION + External

40K+ patient-yrs

Scale · 50+ Clinics (Owned + External)

300K+ patient-yrs

We're working with a select group of family offices and super angels in our seed round.

Request the Investor Brief

Leadership

Operator-built. Clinically grounded. Ready to scale.

Ian Wendt

Founder & CEO

Ian brings three decades of biopharma commercial leadership to INEXION, with deep expertise in launch strategy, market access, and business development. Most recently Chief Commercial Officer at Jaguar Health, he founded INEXION to apply the same revenue discipline that launches blockbuster drugs to a new category: data-driven longevity clinic networks. Co-host of The RealPharma Podcast. MBA, Dalhousie University.

Na-Ri Oh, MD

Co-Founder & COO

Na-Ri is a physician and global biopharma executive whose career uniquely bridges clinical medicine and commercial strategy. MD from Heidelberg University as a Studienstiftung Scholar (awarded to fewer than 0.5% of German students). After practicing as an Infectious Disease physician, she held leadership roles at Boehringer Ingelheim and Gilead Sciences. Co-host of The RealPharma Podcast. Investor at Black Canyon Ventures and VC Fellow at the Material Change Institute.

Nirav Vira

Chief Technology Officer

25+ years building healthcare data platforms and AI-powered SaaS products. At Verana Health, built a data lake spanning 50 million patients and seven years of longitudinal EMR data. At WithMe Health as CTO, architected a multi-product ecosystem with three distinct revenue lines. At Change Healthcare, built the "Single Source of Truth" data infrastructure powering enterprise analytics. B.E., University of Mumbai.

Joel Rabasco

VP Operations

Seasoned healthcare operator with a proven record scaling zero-to-one startups into operating care delivery organizations. COO of ResiHealth (Advanced Primary Care), GM North America at Dreem Health (virtual sleep medicine), Head of Papa Health, and CPO of BOYDSense. Additional enterprise experience from Qualcomm Life and Dell. MS International Management & BS Mechanical Engineering (Honors), UC San Diego.

The infrastructure layer for longevity medicine.

Longevity medicine is generating extraordinary data. Almost none of it is being captured.

We take the burden. You focus on patients.